drugset / Trial / NCT02748993

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

NCT02748993

Phase 1/2 Completed 56 enrolled Amorepacific Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase 1 and 2 study to assess the safety and efficacy of PAC-14028 cream in children with atopic dermatitis.

Timeline

Start
2016-03
Primary completion
2018-09
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown 0.1 % Topical
Subject PAC-14028 Unknown 0.3 % Topical
Subject PAC-14028 Unknown 1 % Topical

Indications